New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
10:00 EDTCOV, ITCI, WCIC, INCY, TRVN, NUTR, IVAC, APL, RTEC, LJPC, HELI, GOLD, KLIC, EPEOn The Fly: Analyst Initiation Summary
Atlas Pipeline Partners (APL) initiated with a Hold at Deutsche Bank... CHC Group (HELI) initiated with a Buy at UBS... EP Energy (EPE) initiated with an Overweight at JPMorgan... Intevac (IVAC) initiated with a Neutral at B. Riley... Kulicke & Soffa (KLIC) initiated with a Buy at B. Riley... La Jolla Pharmaceutical (LJPC) initiated with an Outperform at Wedbush... Nutraceutical (NUTR) initiated with an Outperform at Imperial Capital... Randgold Resources (GOLD) initiated with a Buy at UBS... Rudolph Technologies (RTEC) initiated with a Buy at B. Riley... Trevena (TRVN) initiated with an Outperform at JMP Securities... WCI Communities (WCIC) reinstated with an Outperform at Credit Suisse... Covidien (COV) initiated with a Buy at CRT Capital... Incyte (INCY) coverage assumed with a Buy at BofA/Merrill... Intra-Cellular (ITCI) initiated with an Outperform at Cowen.
News For APL;EPE;HELI;IVAC;KLIC;LJPC;NUTR;GOLD;RTEC;TRVN;WCIC;COV;INCY;ITCI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 3, 2015
16:11 EDTIVACIntevac reports Q2 EPS (1c), may not compare to consensus (10c)
Subscribe for More Information
10:00 EDTTRVNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:02 EDTEPEEP Energy price target lowered to $10 from $15 at Stephens
Subscribe for More Information
08:55 EDTINCYIncyte price target raised to $125 from $115 at Leerink
Leerink raised its price target for Incyte to $125 saying its survey of 49 U.S. hematologists indicated Jakafi has blockbuster potential in polycythemia vera. The firm keeps an Outperform rating on the stock.
05:31 EDTTRVNTrevena initiated with a Buy at Brean Capital
Subscribe for More Information
July 31, 2015
09:43 EDTITCIIntra-Cellular refusal to share ITI-007 poster 'unusual,' says The Street
Subscribe for More Information
06:20 EDTITCIIntra-Cellular could trade to $60-$80 on positive data, says Leerink
Subscribe for More Information
July 30, 2015
07:07 EDTNUTRNutraceutical reports Q3 EPS 47c, one estimate 40c
Subscribe for More Information
July 29, 2015
19:32 EDTEPEOn The Fly: After Hours Movers
Subscribe for More Information
17:41 EDTEPEEP Energy up 5.6% after reporting Q2 results, raising FY15 production guidance
17:41 EDTEPEEP Energy raises FY15 production guidance to 102.25-110.25 MBoe/d
Subscribe for More Information
17:39 EDTEPEEP Energy reports Q2 adjusted EPS 17c vs. 21c last year
Subscribe for More Information
07:03 EDTWCICWCI Communities reports Q2 EPS 37c, consensus 30c
Reports Q2 revenue $150.7M, consensus $140.48M. The company delivered 243 homes in the second quarter, an increase of 100 units, or 69.9% from the prior year period. The average selling price per home delivered during the quarter ended June 30, 2015 was $476,000, an increase of 11.7%, compared to $426,000 in the prior year period. Adjusted gross margin from homes delivered, a non-GAAP financial measure, was 29.1% in the quarter ended June 30, 2015. New orders during the second quarter of 2015 increased 53.8% to 300 homes and the contract value of new orders was $128.6M for the second quarter, an increase of 37.4% from the prior year period. As of June 30, 2015, backlog contract value was $294.1M, an increase of $64.1M, or 27.9% from June 30, 2014. Backlog units totaled 627 units at the end of the second quarter, representing a 194 unit, or 44.8% increase from the prior year.
July 27, 2015
10:40 EDTITCILeerink major pharma analyst holds an analyst/industry conference call
Subscribe for More Information
09:23 EDTITCIIntra-Cellular participates in a conference call with Leerink
Leerink Major Pharmaceuticals Analyst Fernandez, along with Biotech Vice President Matteis, host a conference call with Intra-Cellular President & CEO Mates, Clinical Development VP Vanover and Clinical Affairs VP O'Gorman to discuss ITI-007 in schizophrenia, bipolar depression and other indications on July 30 at 2 pm.
July 24, 2015
10:31 EDTEPEHigh option volume stocks
High option volume stocks: EPE CERS RHI DHT TERP UIS GFI CFX NTGR NNN
10:00 EDTGOLDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:41 EDTGOLDRandgold upgraded to Buy from Neutral at Citi
Subscribe for More Information
July 22, 2015
08:07 EDTITCIIntra-Cellular announces Phase 3 clinical development program
Subscribe for More Information
06:27 EDTEPEEP Energy coverage assumed with an Outperform at Credit Suisse
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use